Month: April 2023

Join this channel to get access to perks: https://www.youtube.com/channel/UCesNt4_Z-Pm41RzpAClfVcg/join Support me: 🖼️ Buy PDFs: http://armandoh.org/shop 💵 Patreon: http://www.patreon.com/armando 👕 Buy shirts: https://teespring.com/stores/ah-7 Social media: 📷 Instagram: http://instagram.com/armandohasudungan 🐦 Twitter: https://twitter.com/armandohasudung 📔 Facebook: https://www.facebook.com/ArmandoHasudungan Resources: 📕 Books: http://armandoh.org/resource 🎞️ Equipment: armandoh.org/armando-faigl You can send me mail: 📫 PO BOX 166, Randwick Post Office, Randwick Plaza, NSW
0 Comments
Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a new all-London partnership announced today (25th April).  MYndspan’s co-founder Caitlin Baltzer, having her brain scanned using magnetoencephalogy (MEG) technology at MYndspan’s Birmingham site. Image Credit: Myndspan Clerkenwell Health, who opened Europe’s first commercial psychedelic clinical trials facility
0 Comments
In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. Anna Moneymaker | Getty Images The abortion pill mifepristone is either banned or restricted to varying degrees in 27 states despite a Supreme Court decision that — for now — maintains Food and
0 Comments
Most often-rural counties in Texas and across the country do not even have one child and adolescent psychiatrist. This is where programs like the Texas Child Health Access through Telemedicine (TCHATT) program, comes into play. TCHATT offers appointments through telemedicine that provide immediate mental health care needed by youth, especially in these days of regularly
0 Comments
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the
0 Comments
A brief scalable suicide risk assessment tool accurately predicts suicide risk in patients with serious mental illness (SMI), a new population-based study shows. The 17-question Oxford Mental Illness and Suicide Tool (OxMIS) assessment is designed to predict 12-month suicide risk in people with schizophrenia spectrum disorders and bipolar disorder based on risk factors such as
0 Comments
The recent approval of the first oral fecal-derived microbiota therapy to prevent the recurrence of Clostridioides difficile (C. diff) infection in patients was welcome news for physicians who’ve struggled under the weight of having too few treatment options for the prevention of C. diff recurrence. The product, developed by Massachusetts-based Seres Therapeutics and marketed as Vowst, was approved by
0 Comments
Incoming Harvard Medical School Dean George Q. Daley shared his vision for the future of HMS and was formally welcomed to his new role by Harvard President Drew Faust at a celebration in the Medical Education Center on Jan. 4. Read the full story at https://hms.harvard.edu/news/celebrating-future Like Harvard Medical School on Facebook: https://goo.gl/4dwXyZ Follow on
0 Comments
Cornelius A. Thiels, D.O., M.B.A., a surgical oncologist at Mayo Clinic in Rochester, Minnesota, explains that surgery is often the best option for patients with colorectal liver metastases. Hepatic artery infusion pump chemotherapy provides a controlled dose of chemotherapy directly to the liver, making surgery an option for some patients. To learn more about surgical
0 Comments
NORWOOD, Mass., April 27, 2023. Entrinsic Bioscience is pleased to announce the upcoming poster session on the role of Enterade® Advanced Oncology Formula in reducing adverse gastrointestinal side effects for patients undergoing cancer treatment. The event will showcase the preliminary results of an ongoing clinical study that is being conducted by a team of researchers
0 Comments
In this article ILMN IEP Follow your favorite stocksCREATE FREE ACCOUNT Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Friday called Illumina’s first-quarter results “very disappointing” and slammed the DNA sequencing company’s new plans to cut costs.  The activist investor, who owns
0 Comments
Hassenfeld Children’s Hospital at NYU Langone has recruited three internationally recognized physicians specializing in pediatric hepatology to deliver comprehensive, family-centered care to children and adolescents with acute and chronic liver disease. Nadia Ovchinsky, MD, Jennifer M. Vittorio, MD, and Debora Kogan-Liberman, MD, have joined Hassenfeld Children’s Hospital and the NYU Langone Transplant Institute to establish
0 Comments